Insider / Aramark
DelGhiaccio Brian M
Director at Aramark
- Company
- Aramark
- First filing on record
- October 17, 2025
- Latest trade on record
- October 15, 2026
- SEC filings
- EDGAR ↗
DelGhiaccio Brian M, Director at Aramark, has disclosed 30 transactions in RSG, ARMK since October 17, 2025: 0 purchases (0 open-market buys) and 5 sales, worth about $1.6M at the reported prices. The latest was filed October 19, 2026, 4 days after the trade; 2 filings were late against the 2-business-day Form 4 deadline.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months DelGhiaccio Brian M made no purchases and 5 sales worth $1.2M, plus 23 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
DelGhiaccio Brian M has traded 1 stock on record; the largest by dollars is RSG.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
1 of 15 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 17 | 15,331 | $323K |
| M | Option exercise or conversion | 8 | 6,762 | — |
| F | Shares withheld for tax | 5 | 5,596 | $1.2M |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 27 | 0 | 5 · $1.2M |
| 2025 | 3 | 0 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| RSG | Other A | October 15, 2026 | October 19, 2026 | 4d | 24 | $230 | $5,617 | derivative | Form 4 ↗ | |
| RSG | Other A | October 15, 2026 | October 19, 2026 | 4d | 93 | $230 | $21K | derivative | Form 4 ↗ | |
| ARMK | Other A | September 9, 2026 | September 10, 2026 | 1d | 35 | — | — | Form 4 ↗ | ||
| RSG | Other A | July 15, 2026 | July 17, 2026 | 2d | 24 | $217 | $5,216 | derivative | Form 4 ↗ | |
| RSG | Other A | July 15, 2026 | July 17, 2026 | 2d | 91 | $217 | $20K | derivative | Form 4 ↗ | |
| ARMK | Other A | June 3, 2026 | June 4, 2026 | 1d | 37 | — | — | Form 4 ↗ | ||
| RSG | Other A | April 15, 2026 | April 17, 2026 | 2d | 25 | $211 | $5,272 | derivative | Form 4 ↗ | |
| RSG | Other A | April 15, 2026 | April 17, 2026 | 2d | 94 | $211 | $20K | derivative | Form 4 ↗ | |
| ARMK | Other A | March 4, 2026 | March 5, 2026 | 1d | 48 | — | — | Form 4 ↗ | ||
| RSG | Option / conversion M | March 1, 2026 | March 2, 2026 | 1d | 904 | — | — | derivative | Form 4 ↗ | |
| RSG | Sell F | March 1, 2026 | March 2, 2026 | 1d | 496 | $229 | $114K | Form 4 ↗ | ||
| RSG | Option / conversion M | March 1, 2026 | March 2, 2026 | 1d | 904 | — | — | Form 4 ↗ | ||
| RSG | Other A | February 19, 2026 | February 23, 2026 | 4d | 2,708 | — | — | derivative | Form 4 ↗ | |
| RSG | Sell F | February 19, 2026 | February 23, 2026 | 4d | 3,708 | $222 | $822K | Form 4 ↗ | ||
| RSG | Other A | February 19, 2026 | February 23, 2026 | 4d | 6,758 | — | — | Form 4 ↗ | ||
| RSG | Option / conversion M | February 18, 2026 | February 20, 2026 | 2d | 564 | — | — | derivative | Form 4 ↗ | |
| RSG | Sell F | February 18, 2026 | February 20, 2026 | 2d | 309 | $217 | $67K | Form 4 ↗ | ||
| RSG | Option / conversion M | February 18, 2026 | February 20, 2026 | 2d | 564 | — | — | Form 4 ↗ | ||
| RSG | Option / conversion M | February 17, 2026 | February 19, 2026 | 2d | 1,254 | — | — | derivative | Form 4 ↗ | |
| RSG | Sell F | February 17, 2026 | February 19, 2026 | 2d | 688 | $221 | $152K | Form 4 ↗ | ||
| RSG | Option / conversion M | February 17, 2026 | February 19, 2026 | 2d | 1,254 | — | — | Form 4 ↗ | ||
| RSG | Option / conversion M | February 11, 2026 | February 13, 2026 | 2d | 659 | — | — | derivative | Form 4 ↗ | |
| RSG | Sell F | February 11, 2026 | February 13, 2026 | 2d | 395 | $226 | $89K | Form 4 ↗ | ||
| RSG | Option / conversion M | February 11, 2026 | February 13, 2026 | 2d | 659 | — | — | Form 4 ↗ | ||
| ARMK | Other A | February 3, 2026 | February 4, 2026 | 1d | 5,124 | $38 | $195K | Form 4 ↗ | ||
| RSG | Other A | January 15, 2026 | January 20, 2026 | 5d | 25 | $211 | $5,270 | latederivative | Form 4 ↗ | |
| RSG | Other A | January 15, 2026 | January 20, 2026 | 5d | 95 | $211 | $20K | latederivative | Form 4 ↗ | |
| ARMK | Other A | December 17, 2025 | December 18, 2025 | 1d | 35 | — | — | Form 4 ↗ | ||
| RSG | Other A | October 15, 2025 | October 17, 2025 | 2d | 24 | $221 | $5,305 | derivative | Form 4 ↗ | |
| RSG | Other A | October 15, 2025 | October 17, 2025 | 2d | 91 | $221 | $20K | derivative | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| October 19, 2026 | Form 4 | 0001060391-26-000308 | 2 | published | EDGAR ↗ |
| September 10, 2026 | Form 4 | 0001584509-26-000143 | 1 | published | EDGAR ↗ |
| July 17, 2026 | Form 4 | 0001060391-26-000256 | 2 | published | EDGAR ↗ |
| June 4, 2026 | Form 4 | 0001584509-26-000090 | 1 | published | EDGAR ↗ |
| April 17, 2026 | Form 4 | 0001060391-26-000194 | 2 | published | EDGAR ↗ |
| March 5, 2026 | Form 4 | 0001584509-26-000069 | 1 | published | EDGAR ↗ |
| March 2, 2026 | Form 4 | 0001060391-26-000148 | 3 | published | EDGAR ↗ |
| February 23, 2026 | Form 4 | 0001060391-26-000127 | 3 | published | EDGAR ↗ |
| February 20, 2026 | Form 4 | 0001060391-26-000117 | 3 | published | EDGAR ↗ |
| February 19, 2026 | Form 4 | 0001060391-26-000098 | 3 | published | EDGAR ↗ |
| February 13, 2026 | Form 4 | 0001060391-26-000083 | 3 | published | EDGAR ↗ |
| February 4, 2026 | Form 4 | 0001584509-26-000024 | 1 | published | EDGAR ↗ |
| January 20, 2026 | Form 4 | 0001060391-26-000046 | 2 | published | EDGAR ↗ |
| December 18, 2025 | Form 4 | 0001584509-25-000236 | 1 | published | EDGAR ↗ |
| October 17, 2025 | Form 4 | 0001060391-25-000260 | 2 | published | EDGAR ↗ |
Other insiders at Aramark
- CASCADE INVESTMENT, L.L.C. Insider 107 rows
- Bales Brian A EVP, Chief Development Officer 44 rows
- Arambula Julia SVP Operations 30 rows
- Richardson Larson SVP Operations 30 rows
- Carlsen Elyse CAO 29 rows
- Bruno Marc A COO, U.S. Food & Facilities 27 rows
- Ellingsen Catharine D EVP/Chief Legal Officer/Sec 25 rows
- TYLER BRIAN S. Chief Executive Officer 24 rows
- ZILLMER JOHN J Director 24 rows
- Brummer Gregg EVP, COO 23 rows
Everyone on file, with contracts and lobbying under the company's name: Aramark.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 15 | 30 | October 17, 2025 | October 19, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.